Population Health
Orchestrate and scale high-volume cancer screening and disease assessment programs
Aiming to enable earlier and more efficient cancer detection and to empower clinicians with information to make more accurate diagnoses for a wide variety of diseases
Book a demoImproving cancer detection rates
76%
Of detected lung cancers found at earlier stages1
21%
Increase in breast cancer detection rate2
Reducing unnecessary recalls
Reduced single reader recall rate to expert level3
Driving operational and clinical excellence
10%
Reduction in reporting time for prostate scans4
92%
Sensitivity in detecting hippocampal atrophy5
Improving staff experience
Generalist radiologists elevated to expert levels6
Seamless scalability – easily accessible and quick to launch from any location
1) New lung cancer screening roll out to detect cancer sooner - GOV.UK (www.gov.uk);
2) SmartMammo Dx + Assure used in a safeguard review process improved cancer detection rate by 21% in a study of over 575,000 patients, showing the same benefits across racial subgroups and patients with different breast densities. Data on file;
3) Data on file;
4) Cipollari et al., Radiologia Medica, 2022;
5) Asl Roma 2, "L’intelligenza artificiale a supporto della diagnosi precoce dei disturbi cognitivi in età
geriatrica," 2024. Available here.
6) Faiella et al., Tomography, 2022;